(IN BRIEF) A new spin-out drug discovery company from the University of Liverpool called Sulantrix is exploring new cancer medicines targeting previously untapped classes of pseudoenzymes. The company is led by Professor Patrick Eyers and CEO David Williams, who has … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AI, Cancer, David Williams, Dr Emma Fairweather, drug discovery, Emma Nolan, Enterprise Investment Funding, ISMIB, Multi-omics Platforms, Professor Anthony Hollander, Professor Patrick Eyers, pseudoenzymes, spin-out, Sulantrix, University of Liverpool
(ACTUALITÉ EN BREF) Une nouvelle société dérivée de découverte de médicaments de l’Université de Liverpool appelée Sulantrix explore de nouveaux médicaments contre le cancer ciblant des classes de pseudoenzymes jusqu’alors inexploitées. La société est dirigée par le professeur Patrick Eyers … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Cancer, David Williams, découverte de médicaments, Dr Emma Fairweather, Emma Nolan, essaimage, financement des investissements d'entreprise, IA, ISMIB, plateformes multi-omiques, professeur Anthony Hollander, professeur Patrick Eyers, pseudoenzymes, Sulantrix, Université de Liverpool
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?